Similar articles

• Alpha-fetoprotein and hepatocellular carcinoma.

  Colli A, Fraquelli M, Conte D. Colli A, et al. Am J Gastroenterol. 2006 Aug;101(8):1939; author reply 1940-1. doi: 10.1111/j.1572-0241.2006.00684_3.x. Am J Gastroenterol. 2006. PMID: 16928257 No abstract available.
• [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].

  Aoyagi Y, Mita Y, Kuroiwa T, Wakuri N, Kawai H, Kobayashi M, Igarashi M, Suda T. Aoyagi Y, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:342-8. Nihon Rinsho. 2001. PMID: 11761969 Review. Japanese. No abstract available.
• Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.

  Wong CB, Attar BM, Shimoda SS. Wong CB, et al. Am J Gastroenterol. 1995 Jun;90(6):1015-6. Am J Gastroenterol. 1995. PMID: 7539578 No abstract available.
• [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].

  Denis I, Beaudonnet A, Pichot J, Roubille M, Gelineau M. Denis I, et al. Ann Biol Clin (Paris). 2000 Jan-Feb;58(1):85-90. Ann Biol Clin (Paris). 2000. PMID: 10673618 French. No abstract available.
• [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].

  Aoyagi Y, Kubota T. Aoyagi Y, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:625-8. Nihon Rinsho. 2005. PMID: 16149595 Review. Japanese. No abstract available.